About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Second Patient Dies in the First Phase of France's Artificial Heart Trial

by Dr. Trupti Shirole on May 5, 2015 at 7:21 PM
Second Patient Dies in the First Phase of France's Artificial Heart Trial

Artificial hearts are used as a temporary fix for patients with chronic heart problems. Biomedical firm Carmat has designed a self-contained unit, which is a mix of synthetic materials and animal tissue, and seeks to mimic the form and function of an actual human heart.

This artificial heart uses soft bio-materials intended to lessen the risk of blood clots and rejection by the immune system. It is powered by a belt of lithium batteries. Carmat was hoping to provide a longer-term solution to tens of thousands who suffer from heart disease and are unable to receive a transplant. However, the second person in France to have received this new-generation artificial heart has died eight months after receiving the transplant.

Advertisement

The 69-year-old man, who wished to remain anonymous, was terminally ill when he received this experimental heart that was seen as a long-term solution for patients with end-stage heart failure. Carmat said, "The patient was admitted to hospital on Friday with circulatory collapse." A medical team noted the heart was not functioning correctly and therefore a new device was transplanted, however the patient died on Saturday from post-operative complications.

Carmat's first trial of the device on a 76-year-old man ended March 2, 2015, with the patient's death after two and a half months. The French firm's trial was to involve four people. A third patient was confirmed to have received the artificial heart last week. The first phase of the trial will be considered to be successful if patients survive for a month after the transplant. Carmat will then carry out a second phase of clinical trials which will involve 20 heart patients.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Clinical Trials News

Injecting Platelets Could be as Beneficial as Exercising to the Brain
Increasing the levels of platelet-derived factors in the body may lessen the effect of age-related degenerative changes and cognitive impairment in the brain.
Engineered Bacteria Offer New Hope for Early Cancer Detection
Constructing bacteria to become drug resistant only when they took up DNA containing cancer-associated changes, could be useful in detecting cancer.
Is Eli Lilly's Drug the Future of Obesity Treatment?
Eli Lilly's Mounjaro may prove an alternative to bariatric surgery, stated clinical trial results.
Made In India 'Liquid Cornea' Will Soon Undergo Human Trial
After achieving an 80 percent success rate in treating animals, Indian doctors plan to advance to human trials for the liquid cornea.
 Stop the Bleeding and Save Lives With a Perfume Ingredient
Recent research in rats has shown that a common perfume ingredient may have the potential to stop massive hemorrhages (bleeding) and save lives in gunshot injuries.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Second Patient Dies in the First Phase of France's Artificial Heart Trial Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests